Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253863189> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W4253863189 abstract "Abstract Background: The identification of novel targets for recovering sorafenib resistance is pivotal for Hepatocellular carcinoma (HCC) patients. Mitophagy is the programmed degradation of mitochondria, and is likely involved in drug resistance of cancer cells. Here, we identified hyperactivated mitophagy is essential for sorafenib resistance, and the mitophagy core regulator gene ATAD3A (ATPase family AAA domain containing 3A) was down regulated in hypoxia induced resistant HCC cells. Blocking mitophagy may restore the sorafenib sensitivity of these cells and provide a new treatment strategy for HCC patients. Methods: Hypoxia induced sorafenib resistant cancer cells were established by culturing under 1% O 2 with increasing drug treatment. RNA sequencing was conducted in transfecting LM3 cells with sh-ATAD3A lentivirus. Subsequent mechanistic studies were performed in HCC cell lines by manipulating ATAD3A expression isogenically where we evaluated drug sensitivity, molecular signaling events. In vivo study, we investigated the combined treatment effect of sorafenib and miR-210-5P antagomir. Results: We found a hyperactivated mitophagy regulating by ATAD3A-PINK/PARKIN axis in hypoxia induced sorafenib resistant HCC cells. Gain- and loss- of ATAD3A were related to hypoxia-induced mitophagy and sorafenib resistance. In addition, ATAD3A is a functional target of miR-210-5p and its oncogenic functions are likely mediated by increased miR-210-5P expression. miR-210-5P was upregulated under hypoxia and participated in regulating sorafenib resistance. In vivo xenograft assay showed that miR-210-5P antagomir combined with sorafenib abrogated the tumorigenic effect of ATAD3A down-regulation in mice. Conclusions: Loss of ATAD3A hyperactivates mitophagy which is a core event in hypoxia induced sorafenib resistance in HCC cells. Targeting miR-210-5P-ATAD3A axis is a novel therapeutic target for sorafenib-resistant HCC. Keywords: Mitophagy, ATAD3A, Hypoxia, Sorafenib resistance" @default.
- W4253863189 created "2022-05-12" @default.
- W4253863189 creator A5002621017 @default.
- W4253863189 creator A5022526821 @default.
- W4253863189 creator A5026847991 @default.
- W4253863189 creator A5032940656 @default.
- W4253863189 creator A5033732336 @default.
- W4253863189 creator A5046537879 @default.
- W4253863189 creator A5049475719 @default.
- W4253863189 creator A5054637200 @default.
- W4253863189 creator A5056588891 @default.
- W4253863189 creator A5064712081 @default.
- W4253863189 creator A5067031552 @default.
- W4253863189 creator A5073203414 @default.
- W4253863189 creator A5076360056 @default.
- W4253863189 creator A5085142676 @default.
- W4253863189 date "2020-11-11" @default.
- W4253863189 modified "2023-09-26" @default.
- W4253863189 title "Mitophagy Promotes Sorafenib Resistance through Hypoxia-Inducible ATAD3A Dependent Axis" @default.
- W4253863189 doi "https://doi.org/10.21203/rs.3.rs-48449/v2" @default.
- W4253863189 hasPublicationYear "2020" @default.
- W4253863189 type Work @default.
- W4253863189 citedByCount "0" @default.
- W4253863189 crossrefType "posted-content" @default.
- W4253863189 hasAuthorship W4253863189A5002621017 @default.
- W4253863189 hasAuthorship W4253863189A5022526821 @default.
- W4253863189 hasAuthorship W4253863189A5026847991 @default.
- W4253863189 hasAuthorship W4253863189A5032940656 @default.
- W4253863189 hasAuthorship W4253863189A5033732336 @default.
- W4253863189 hasAuthorship W4253863189A5046537879 @default.
- W4253863189 hasAuthorship W4253863189A5049475719 @default.
- W4253863189 hasAuthorship W4253863189A5054637200 @default.
- W4253863189 hasAuthorship W4253863189A5056588891 @default.
- W4253863189 hasAuthorship W4253863189A5064712081 @default.
- W4253863189 hasAuthorship W4253863189A5067031552 @default.
- W4253863189 hasAuthorship W4253863189A5073203414 @default.
- W4253863189 hasAuthorship W4253863189A5076360056 @default.
- W4253863189 hasAuthorship W4253863189A5085142676 @default.
- W4253863189 hasBestOaLocation W42538631891 @default.
- W4253863189 hasConcept C104317684 @default.
- W4253863189 hasConcept C121608353 @default.
- W4253863189 hasConcept C126322002 @default.
- W4253863189 hasConcept C127561419 @default.
- W4253863189 hasConcept C150903083 @default.
- W4253863189 hasConcept C178790620 @default.
- W4253863189 hasConcept C185592680 @default.
- W4253863189 hasConcept C190283241 @default.
- W4253863189 hasConcept C203522944 @default.
- W4253863189 hasConcept C207001950 @default.
- W4253863189 hasConcept C2778019345 @default.
- W4253863189 hasConcept C2778695046 @default.
- W4253863189 hasConcept C2779324830 @default.
- W4253863189 hasConcept C2779368916 @default.
- W4253863189 hasConcept C502942594 @default.
- W4253863189 hasConcept C540031477 @default.
- W4253863189 hasConcept C55493867 @default.
- W4253863189 hasConcept C71924100 @default.
- W4253863189 hasConcept C7836513 @default.
- W4253863189 hasConcept C86803240 @default.
- W4253863189 hasConcept C96232424 @default.
- W4253863189 hasConceptScore W4253863189C104317684 @default.
- W4253863189 hasConceptScore W4253863189C121608353 @default.
- W4253863189 hasConceptScore W4253863189C126322002 @default.
- W4253863189 hasConceptScore W4253863189C127561419 @default.
- W4253863189 hasConceptScore W4253863189C150903083 @default.
- W4253863189 hasConceptScore W4253863189C178790620 @default.
- W4253863189 hasConceptScore W4253863189C185592680 @default.
- W4253863189 hasConceptScore W4253863189C190283241 @default.
- W4253863189 hasConceptScore W4253863189C203522944 @default.
- W4253863189 hasConceptScore W4253863189C207001950 @default.
- W4253863189 hasConceptScore W4253863189C2778019345 @default.
- W4253863189 hasConceptScore W4253863189C2778695046 @default.
- W4253863189 hasConceptScore W4253863189C2779324830 @default.
- W4253863189 hasConceptScore W4253863189C2779368916 @default.
- W4253863189 hasConceptScore W4253863189C502942594 @default.
- W4253863189 hasConceptScore W4253863189C540031477 @default.
- W4253863189 hasConceptScore W4253863189C55493867 @default.
- W4253863189 hasConceptScore W4253863189C71924100 @default.
- W4253863189 hasConceptScore W4253863189C7836513 @default.
- W4253863189 hasConceptScore W4253863189C86803240 @default.
- W4253863189 hasConceptScore W4253863189C96232424 @default.
- W4253863189 hasLocation W42538631891 @default.
- W4253863189 hasLocation W42538631892 @default.
- W4253863189 hasLocation W42538631893 @default.
- W4253863189 hasOpenAccess W4253863189 @default.
- W4253863189 hasPrimaryLocation W42538631891 @default.
- W4253863189 hasRelatedWork W2043682963 @default.
- W4253863189 hasRelatedWork W2085937712 @default.
- W4253863189 hasRelatedWork W2353834389 @default.
- W4253863189 hasRelatedWork W2791298525 @default.
- W4253863189 hasRelatedWork W2976498648 @default.
- W4253863189 hasRelatedWork W3110441183 @default.
- W4253863189 hasRelatedWork W3158627588 @default.
- W4253863189 hasRelatedWork W4255741869 @default.
- W4253863189 hasRelatedWork W4366608273 @default.
- W4253863189 hasRelatedWork W4366964620 @default.
- W4253863189 isParatext "false" @default.
- W4253863189 isRetracted "false" @default.
- W4253863189 workType "article" @default.